Lobaplatin-based concurrent chemoradiotherapy in elderly nasopharyngeal carcinoma.

Yi-Feng YuPing ZhouRui ZhouQin LinSan-Gang Wu

Published in: Annals of medicine (2024)

Lobaplatin-based CCRT is safe and feasible for elderly NPC patients, with satisfactory short-term survival outcomes and acceptable toxicities. A phase 2 trial is ongoing to investigate the role of lobaplatin-based CCRT on long-term survival and treatment toxicities for this population.

Keyphrases

middle aged
locally advanced
community dwelling
rectal cancer
replacement therapy